Beyond DTC: Pharma Industry Faces New Challenges, Competition, Strategies for Market...( NEW YORK Jan. 15 /- As drastic cu...)

NEW YORK, Jan. 15 /PRNewswire/ -- As drastic cutbacks at major pharmaceuticals continue, competition soars from generics and challenge blockbuster drug teams. Social networks have entered the zone of physician and patient encounters. Advertising expenditures are being scrutinized for ROI. Product recalls and drug safety warnings pose new issues and responsibilities on drug marketers. Yet new marketing opportunities have opened up with the growth of multicultural segments, new technologies, media channels and sales force optimization tools.

This year's 2nd Annual Pharmaceutical Sales & Marketing Executive Congress, scheduled for March 31 - April 1, 2008 in Bethesda, Maryland brings together an impressive line-up of experts and industry leaders who will outline trends, case studies, and best-practices required to reformulate pharmaceutical marketing and sales strategies in the light of the new rules of engagement in this industry. Speaking faculty includes:

-- Hon. Gene Green (D-TX), Member, Health Subcommittee - Energy & Commerce

Committee, U. S. House of Representatives

-- Paul J. Savidge, VP, Global Labeling & Compliance, Bristol-Myers Squibb

-- Liliana A. Gil, Worldwide Director of Marketing Services & Hispanic

Strategy Lead, Johnson & Johnson

-- Ellen Shapiro, Director, Division of Communications, Center for Drug

Evaluation and Research (CDER), FDA

-- David Lampinski, Associate Director, Commercial Analytics, Sepracor

Inc.

-- Jeannie Miller, Managed Markets, Jazz Pharmaceuticals

-- Glenn Byrd, VP, Regulatory Affairs, MedImmune

-- Chris Bogan, CEO, Best Practices LLC

-- John Mack, Publisher, Pharma Marketing News

-- Robin L. Winter-Sperry, M.D., President & CEO, Scientific Advantage

-- Nayan Shah M.D., Associate Professor of Medicine, Georgetown University

Medical Center

-- Hugo Stephenson, M.D., President, iGuard.Or
'/>"/>